HUTCHMED (China) (HCM) Current Deferred Revenue (2015 - 2025)

HUTCHMED (China) (HCM) has 10 years of Current Deferred Revenue data on file, last reported at $6.6 million in Q4 2025.

• On a quarterly basis, Current Deferred Revenue fell 47.69% year-over-year to $6.6 million in Q4 2025; TTM through Dec 2025 was $6.6 million, a 47.69% decrease from a year earlier, with the FY2025 full-year figure at $31.4 million, up 148.85% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $6.6 million, down from $46.8 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for HCM reached as high as $16.3 billion in Q4 2023 and fell as low as $1.7 million in Q4 2022.
• Historically, Current Deferred Revenue has averaged $2.3 billion across 4 years, with a median of $46.8 million in 2025.
• Across the five-year window, Current Deferred Revenue soared 939994.2% in 2023 and plunged 99.92% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $1.7 million in 2022, then surged by 939994.2% to $16.3 billion in 2023, then plunged by 99.92% to $12.7 million in 2024, then sank by 47.69% to $6.6 million in 2025.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $6.6 million in Q4 2025, $46.8 million in Q2 2025, and $12.7 million in Q4 2024.